home / stock / allk / allk quote
Last: | $1.02 |
---|---|
Change Percent: | -1.98% |
Open: | $1.03 |
Close: | $1.02 |
High: | $1.03 |
Low: | $0.9807 |
Volume: | 425,735 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.02 | $1.03 | $1.02 | $1.03 | $0.9807 | 425,735 | 04-26-2024 |
$1.01 | $1.01 | $1.01 | $1.045 | $0.9799 | 396,845 | 04-25-2024 |
$1.02 | $1.05 | $1.02 | $1.1 | $1.02 | 162,903 | 04-24-2024 |
$1.05 | $1.05 | $1.05 | $1.1 | $1.05 | 266,041 | 04-23-2024 |
$1.06 | $1.06 | $1.06 | $1.08 | $1.03 | 279,232 | 04-22-2024 |
$1.07 | $1.05 | $1.07 | $1.09 | $1.02 | 415,801 | 04-19-2024 |
$1.06 | $1.09 | $1.06 | $1.12 | $1.025 | 424,758 | 04-18-2024 |
$1.06 | $1.04 | $1.06 | $1.08 | $1.03 | 336,718 | 04-17-2024 |
$1.05 | $1.07 | $1.05 | $1.1 | $1 | 302,835 | 04-16-2024 |
$1.08 | $1.14 | $1.08 | $1.14 | $1.04 | 640,303 | 04-15-2024 |
$1.11 | $1.21 | $1.11 | $1.2136 | $1.1 | 409,765 | 04-12-2024 |
$1.21 | $1.17 | $1.21 | $1.22 | $1.15 | 354,668 | 04-11-2024 |
$1.16 | $1.15 | $1.16 | $1.18 | $1.1 | 459,311 | 04-10-2024 |
$1.2 | $1.14 | $1.2 | $1.21 | $1.13 | 356,727 | 04-09-2024 |
$1.13 | $1.17 | $1.13 | $1.18 | $1.11 | 560,645 | 04-08-2024 |
$1.19 | $1.21 | $1.19 | $1.22 | $1.165 | 503,082 | 04-05-2024 |
$1.23 | $1.28 | $1.23 | $1.295 | $1.21 | 487,670 | 04-04-2024 |
$1.28 | $1.21 | $1.28 | $1.31 | $1.2 | 513,785 | 04-03-2024 |
$1.24 | $1.2 | $1.24 | $1.26 | $1.18 | 414,692 | 04-02-2024 |
$1.22 | $1.27 | $1.22 | $1.28 | $1.18 | 599,580 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Allakos Inc. Company Name:
ALLK Stock Symbol:
NASDAQ Market:
SAN CARLOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results f...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...